Fast Assessment of Solutions, Therapeutics, Pharmaceuticals, and SupplieS (FASTPASS) Innovative Solutions Opening
Solicitation from the National Institutes of Health, for work in District of Columbia. Due Nov 10, 2026, 4:00 PM (UTC-5), 23 days left.
| Solicitation number | ARPA-H-SOL-26-160 |
|---|---|
| Agency | National Institutes of Health |
| Office | Advanced Research Projects Agency for Health (ARPA-H) |
| Notice type | Solicitation |
| Set-aside | None |
| Trade (NAICS) | Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) (541715) |
| Product or service code | AN13 |
| Place of performance | District of Columbia |
| Posted | Aug 20, 2026 |
| Response deadline | Nov 10, 2026, 4:00 PM (UTC-5) (23 days left) |
Official notice and attachments
Description
The Advanced Research Projects Agency for Health (ARPA-H) Fast Assessment of Solutions, Therapeutics, Pharmaceuticals, and SupplieS (FASTPASS) program aims to develop a near real-time, non-destructive, AI-enabled system for screening pharmaceutical products and inputs through their packaging at ports of entry and other supply-chain nodes. Interested parties are invited to review the attached FASTPASS Innovative Solutions Opening, ARPA-H-SOL-26-160.
About the buyer
The National Institutes of Health awarded $5.8 billion in contracts in the last 12 months; its biggest suppliers were Leidos Biomedical Research Inc, M. A. Mortenson Company and Deloitte Consulting LLP. See what NIH is buying now.